While specific studies directly linking SFRP3 and neuroendocrine tumor proliferation are limited, mechanisms observed in other cancer types suggest that SFRP3 likely influences neuroendocrine tumor growth through similar pathways [61]. This evidence concerns the gene FRZB and neuroendocrine neoplasm.